15 April 2020
Moderna has begun enrolment of participants for the highest dose arm of the Phase I clinical trial assessing its mRNA-1273 vaccine candidate against Covid-19. Led by the US National Institutes of Health (NIH), the trial is designed to include arms for 25μg, 100μg and 250μg dose levels of mRNA-1273.
Merck Group subsidiary MilliporeSigma has agreed to support The Jenner Institute in Oxford, UK, in the large-scale manufacturing of the latter’s Covid-19 vaccine candidate, ChAdOx1 nCoV-19. The partners worked together to cut the manufacturing process time from approximately 6-12 months to two months.
NantKwest and ImmunityBio are in discussions with the US Food and Drug Administration (FDA) regarding the development of Covid-19 vaccines and therapeutics. The collaboration combines ImmunityBio’s vaccine development and natural killer cell activation capabilities with NantKwest’s off-the-shelf, cell-based therapeutics expertise. Read the full story here.
Clara Health has partnered with Lyft and public relations firm VSC to launch an initiative to enhance Covid-19 participation by matching patients to relevant clinical trials. Clara Health developed a registry platform and database called World Without COVID, which lists more than 300 Covid-19 trials; the database is open for researchers and public.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData